PEARLS (ACTG A5175): A Multinational Study of Didanosine-EC, Emtricitabine and Atazanavir vs. Co-Formulated Zidovudine/lamivudine and Efavirenz for Initial Treatment of HIV-1 Infection
High Rate of Virologic Success with Raltegravir Plus Etravirine and Darunavir/Ritonavir in Treatment-Experienced Patients with Multidrug-Resistant Virus: Results of the ANRS 139 TRIO Trial
Yazdan Yazdanpanah, M.D., Ph.D. Service Universitaire des Maladies Infectieuses Centre Hospitalier de Tourcoing